6137 search
Vertex Pharmaceuticals Incorporated
NASDAQ VRTX 494,33 US$ 21,49%
Logo

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

Publié le 20 mai 2015

Pour voir l'article original, cliquez ici .

Les autres articles de la compagnie
How to play weak Q2 earnings season: Analysts
What You Need To Know In Biotech: An ASCO Disappointment, Bi
Vertex Could Give Investors Vertigo
Gilead: No Big Deals
Vertex Pharmaceuticals (VRTX) Stock Climbs Following FDA Adv
Articles en illimité et contenus premium Je m'abonne
Editoriaux
et Nouvelles
Actions
Minières
Or et
Argent
Marchés La Cote
search 6137
search